Abilify Asimtufii, Long-Acting Injection, Approved for Schizophrenia and Bipolar Disorder
A new extended-release form of Abilify (aripiprazole) can be given once every two months for people with bipolar I disorder and schizophrenia.
United States Abilify Maintena Abilify Asimtufii Travis Krew Treatment Advocacy Center National Institute Of Mental Health
Source: everydayhealth.com